IMP
Process View
positive regulation of t cell proliferation
Any process that activates or increases the rate or extent of T cell proliferation.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of t cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| LCK | lymphocyte-specific protein tyrosine kinase | 0.995 | ||
| IL1B | interleukin 1, beta | 0.956 | ||
| SYK | spleen tyrosine kinase | 0.909 | Mouse | |
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.886 | Human | |
| ICAM1 | intercellular adhesion molecule 1 | 0.885 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.882 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.860 | ||
| CD86 | CD86 molecule | 0.847 | Human Mouse Rat | |
| CD80 | CD80 molecule | 0.833 | Mouse Rat | |
| CD2 | CD2 molecule | 0.761 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.759 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.735 | Human | |
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.729 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.726 | ||
| CD247 | CD247 molecule | 0.682 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.680 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.644 | Human | |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.638 | ||
| IL8 | interleukin 8 | 0.624 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.569 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.565 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.526 | ||
| IL4R | interleukin 4 receptor | 0.456 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.447 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.412 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.399 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.398 | ||
| LST1 | leukocyte specific transcript 1 | 0.393 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.390 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.366 | ||
| EGFR | epidermal growth factor receptor | 0.364 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.352 | ||
| HCK | hemopoietic cell kinase | 0.332 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.327 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.300 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.294 | ||
| IFNG | interferon, gamma | 0.293 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.281 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.251 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.249 | ||
| IL10 | interleukin 10 | 0.247 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.246 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.242 | Human | |
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.241 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.238 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.237 | ||
| CD1C | CD1c molecule | 0.231 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.230 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.226 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.225 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.223 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.217 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.217 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.214 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.211 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.206 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.199 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.192 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.190 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.190 | ||
| IDE | insulin-degrading enzyme | 0.189 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.187 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 0.186 | Human | |
| GRAP2 | GRB2-related adaptor protein 2 | 0.178 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.174 | Human | |
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.174 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.169 | ||
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.169 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.165 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.164 | ||
| JAK1 | Janus kinase 1 | 0.158 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.156 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.146 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.137 | ||
| SPTB | spectrin, beta, erythrocytic | 0.136 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.134 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.134 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.132 | ||
| CD52 | CD52 molecule | 0.131 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.129 | ||
| IL2RB | interleukin 2 receptor, beta | 0.129 | ||
| CD33 | CD33 molecule | 0.128 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.125 | ||
| CD1B | CD1b molecule | 0.123 | Human | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.122 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.121 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.120 | Human | |
| NLRP3 | NLR family, pyrin domain containing 3 | 0.119 | ||
| IL6R | interleukin 6 receptor | 0.115 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.113 | ||
| INSR | insulin receptor | 0.110 | ||
| RGS19 | regulator of G-protein signaling 19 | 0.110 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.110 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.107 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.103 | ||
| MEFV | Mediterranean fever | 0.097 | ||
| SH2D1A | SH2 domain containing 1A | 0.097 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.096 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.095 | ||
| CD28 | CD28 molecule | 0.091 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.091 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.090 | ||
| IL7R | interleukin 7 receptor | 0.089 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.088 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.086 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.086 | Human | |
| TRAF3 | TNF receptor-associated factor 3 | 0.086 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.085 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.084 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.083 | Human | |
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.083 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.083 | ||
| IRF4 | interferon regulatory factor 4 | 0.081 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.079 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.076 | ||
| CD1A | CD1a molecule | 0.074 | Human | |
| TNF | tumor necrosis factor | 0.072 | ||
| SLA | Src-like-adaptor | 0.071 | ||
| ATM | ataxia telangiectasia mutated | 0.071 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.070 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.070 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.067 | Mouse | |
| LY86 | lymphocyte antigen 86 | 0.065 | ||
| IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.065 | ||
| BCL2A1 | BCL2-related protein A1 | 0.064 | ||
| JAK2 | Janus kinase 2 | 0.064 | ||
| CD48 | CD48 molecule | 0.064 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.064 | ||
| CD83 | CD83 molecule | 0.063 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.062 | Human | |
| HK3 | hexokinase 3 (white cell) | 0.061 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.060 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.059 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.059 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.059 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.059 | Human Mouse | |
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.057 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.057 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.057 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.056 | Mouse | |
| ICOS | inducible T-cell co-stimulator | 0.056 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.055 | ||
| ITK | IL2-inducible T-cell kinase | 0.054 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.054 | Human | |
| CSK | c-src tyrosine kinase | 0.053 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.053 | ||
| TOP3A | topoisomerase (DNA) III alpha | 0.053 | ||
| PLEK | pleckstrin | 0.052 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.052 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.051 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.050 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.048 | ||
| INO80B | INO80 complex subunit B | 0.048 | ||
| CD40LG | CD40 ligand | 0.047 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.047 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.047 | Human | |
| CH25H | cholesterol 25-hydroxylase | 0.047 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.047 | ||
| UBD | ubiquitin D | 0.045 | ||
| LAT | linker for activation of T cells | 0.045 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.045 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.043 | Human | |
| ADAM12 | ADAM metallopeptidase domain 12 | 0.043 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.043 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.042 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.041 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.041 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.041 | ||
| SLAMF7 | SLAM family member 7 | 0.040 | ||
| AIF1 | allograft inflammatory factor 1 | 0.038 | ||
| OSMR | oncostatin M receptor | 0.037 | Human | |
| CPD | carboxypeptidase D | 0.037 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.037 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.037 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.037 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.036 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.036 | ||
| C1R | complement component 1, r subcomponent | 0.036 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.036 | ||
| IL21R | interleukin 21 receptor | 0.036 | ||
| FYB | FYN binding protein | 0.036 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.036 | ||
| SELL | selectin L | 0.035 | ||
| C1S | complement component 1, s subcomponent | 0.035 | ||
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | 0.035 | ||
| TLR3 | toll-like receptor 3 | 0.035 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.035 | ||
| FPR3 | formyl peptide receptor 3 | 0.034 | ||
| NNMT | nicotinamide N-methyltransferase | 0.034 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.034 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.034 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.034 | ||
| CD5 | CD5 molecule | 0.034 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.034 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.033 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.033 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.032 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.032 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.031 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.031 | ||
| TLR2 | toll-like receptor 2 | 0.031 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.031 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.030 | Human | |
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.030 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.030 | ||
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.030 | ||
| SELE | selectin E | 0.030 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.029 | ||
| CD1E | CD1e molecule | 0.029 | Human | |
| CD6 | CD6 molecule | 0.029 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.029 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.029 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.029 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.028 | ||
| RAD51L3 | RAD51-like 3 (S. cerevisiae) | 0.028 | ||
| INHBA | inhibin, beta A | 0.028 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.028 | ||
| BLNK | B-cell linker | 0.027 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.027 | ||
| CFP | complement factor properdin | 0.027 | ||
| IL13 | interleukin 13 | 0.026 | ||
| DARC | Duffy blood group, chemokine receptor | 0.026 | ||
| IRS1 | insulin receptor substrate 1 | 0.025 | ||
| TF | transferrin | 0.025 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.025 | ||
| CD69 | CD69 molecule | 0.024 | ||
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.024 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.024 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.024 | Human | |
| CD7 | CD7 molecule | 0.024 | ||
| BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.024 | Human | |
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.023 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.023 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.023 | ||
| CD37 | CD37 molecule | 0.023 | ||
| MBD4 | methyl-CpG binding domain protein 4 | 0.023 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.023 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.023 | ||
| TYMP | thymidine phosphorylase | 0.023 | ||
| CD84 | CD84 molecule | 0.023 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.022 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.022 | ||
| C2 | complement component 2 | 0.022 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.022 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.022 | ||
| DPT | dermatopontin | 0.022 | ||
| CD22 | CD22 molecule | 0.022 | ||
| CD8A | CD8a molecule | 0.021 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.021 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.021 | Human | |
| MARCO | macrophage receptor with collagenous structure | 0.021 | ||
| CD1D | CD1d molecule | 0.021 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.021 | ||
| FGL2 | fibrinogen-like 2 | 0.021 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.021 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.021 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.021 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.021 | ||
| AIM2 | absent in melanoma 2 | 0.020 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.020 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.020 | ||
| LBP | lipopolysaccharide binding protein | 0.020 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.020 | ||
| BID | BH3 interacting domain death agonist | 0.020 | ||
| IL1A | interleukin 1, alpha | 0.020 | Human | |
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.020 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.020 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.020 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.019 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.019 | ||
| FCAR | Fc fragment of IgA, receptor for | 0.019 | Human | |
| CD300C | CD300c molecule | 0.019 | ||
| RIPK4 | receptor-interacting serine-threonine kinase 4 | 0.019 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.019 | Human | |
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.019 | Human | |
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.019 | ||
| LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 0.019 | Human | |
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.019 | ||
| DDR1 | discoidin domain receptor tyrosine kinase 1 | 0.019 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.018 | ||
| DNTT | deoxynucleotidyltransferase, terminal | 0.018 | ||
| CD163 | CD163 molecule | 0.018 | ||
| FN1 | fibronectin 1 | 0.018 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.018 | ||
| TFEC | transcription factor EC | 0.018 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.018 | ||
| TYROBP | TYRO protein tyrosine kinase binding protein | 0.018 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.018 | Mouse | |
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.018 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.017 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.017 | ||
| P2RY13 | purinergic receptor P2Y, G-protein coupled, 13 | 0.017 | ||
| IRF8 | interferon regulatory factor 8 | 0.017 | ||
| PTAFR | platelet-activating factor receptor | 0.017 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.017 | Mouse | |
| GHR | growth hormone receptor | 0.017 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.017 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.017 | ||
| IL9 | interleukin 9 | 0.017 | ||
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.017 | ||
| CD8B | CD8b molecule | 0.017 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.017 | ||
| C3AR1 | complement component 3a receptor 1 | 0.016 | ||
| OSM | oncostatin M | 0.016 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.016 | ||
| CD209 | CD209 molecule | 0.016 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.016 | ||
| DENND1C | DENN/MADD domain containing 1C | 0.016 | ||
| PLAU | plasminogen activator, urokinase | 0.016 | ||
| TRAT1 | T cell receptor associated transmembrane adaptor 1 | 0.016 | ||
| GPR109B | G protein-coupled receptor 109B | 0.016 | ||
| HDAC9 | histone deacetylase 9 | 0.016 | ||
| TNC | tenascin C | 0.016 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.016 | ||
| CSNK1E | casein kinase 1, epsilon | 0.016 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.016 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.016 | Human | |
| S100A9 | S100 calcium binding protein A9 | 0.016 | ||
| ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 0.016 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.015 | ||
| XCL1 | chemokine (C motif) ligand 1 | 0.015 | ||
| CD274 | CD274 molecule | 0.015 | Human Rat | |
| LILRA4 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 | 0.015 | ||
| IL13RA1 | interleukin 13 receptor, alpha 1 | 0.015 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.015 | ||
| HCP5 | HLA complex P5 | 0.015 | ||
| FHL1 | four and a half LIM domains 1 | 0.015 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.015 | Human | |
| CCR9 | chemokine (C-C motif) receptor 9 | 0.015 | ||
| DCN | decorin | 0.015 | ||
| TANK | TRAF family member-associated NFKB activator | 0.015 | ||
| CNTF | ciliary neurotrophic factor | 0.015 | ||
| UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) | 0.015 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.015 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.014 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.014 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.014 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.014 | ||
| TLR8 | toll-like receptor 8 | 0.014 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.014 | ||
| EFNB2 | ephrin-B2 | 0.014 | ||
| NKG7 | natural killer cell group 7 sequence | 0.014 | ||
| NRG1 | neuregulin 1 | 0.014 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.014 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.014 | Mouse | |
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.014 | ||
| CECR1 | cat eye syndrome chromosome region, candidate 1 | 0.014 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.014 | ||
| LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.014 | ||
| NBL1 | neuroblastoma, suppression of tumorigenicity 1 | 0.014 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.014 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.014 | ||
| IL4 | interleukin 4 | 0.014 | Mouse | |
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.014 | ||
| CD164 | CD164 molecule, sialomucin | 0.014 | ||
| S100A12 | S100 calcium binding protein A12 | 0.014 | ||
| MSC | musculin | 0.014 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.014 | ||
| ITGB7 | integrin, beta 7 | 0.014 | ||
| SH2D2A | SH2 domain containing 2A | 0.013 | ||
| PTK6 | PTK6 protein tyrosine kinase 6 | 0.013 | ||
| CCR8 | chemokine (C-C motif) receptor 8 | 0.013 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.013 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.013 | ||
| KYNU | kynureninase | 0.013 | ||
| SELPLG | selectin P ligand | 0.013 | ||
| CD226 | CD226 molecule | 0.013 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.013 | ||
| IL32 | interleukin 32 | 0.013 | ||
| C3 | complement component 3 | 0.013 | ||
| TM7SF4 | transmembrane 7 superfamily member 4 | 0.013 | ||
| SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.013 | ||
| GPR84 | G protein-coupled receptor 84 | 0.013 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.013 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.013 | ||
| CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | 0.013 | ||
| DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 0.013 | ||
| CD4 | CD4 molecule | 0.013 | ||
| RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 0.013 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.013 | ||
| STC1 | stanniocalcin 1 | 0.013 | ||
| AQP9 | aquaporin 9 | 0.013 | ||
| CD101 | CD101 molecule | 0.013 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.013 | ||
| DOK2 | docking protein 2, 56kDa | 0.013 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.012 | ||
| FGB | fibrinogen beta chain | 0.012 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.012 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.012 | ||
| PLAT | plasminogen activator, tissue | 0.012 | ||
| TARP | TCR gamma alternate reading frame protein | 0.012 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.012 | ||
| CD180 | CD180 molecule | 0.012 | ||
| APOC1 | apolipoprotein C-I | 0.012 | ||
| RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.012 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.012 | Mouse | |
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.012 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.012 | ||
| RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.012 | ||
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.012 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.012 | ||
| SLAMF8 | SLAM family member 8 | 0.012 | ||
| BIN2 | bridging integrator 2 | 0.012 | ||
| ANK1 | ankyrin 1, erythrocytic | 0.012 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.012 | ||
| NOV | nephroblastoma overexpressed gene | 0.012 | ||
| IFNB1 | interferon, beta 1, fibroblast | 0.012 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.012 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.012 | ||
| CTSW | cathepsin W | 0.012 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.012 | ||
| HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.012 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.012 | ||
| KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.012 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.012 | ||
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.012 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.011 | ||
| GPR171 | G protein-coupled receptor 171 | 0.011 | ||
| GPR132 | G protein-coupled receptor 132 | 0.011 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.011 | ||
| CAPN1 | calpain 1, (mu/I) large subunit | 0.011 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.011 | ||
| SNX9 | sorting nexin 9 | 0.011 | ||
| IL15 | interleukin 15 | 0.011 | Mouse | |
| KIAA1217 | KIAA1217 | 0.011 | ||
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.011 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.011 | ||
| FLT3 | fms-related tyrosine kinase 3 | 0.011 | ||
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.011 | Human | |
| CFI | complement factor I | 0.011 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.011 | ||
| MGP | matrix Gla protein | 0.011 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.011 | Human | |
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.011 | ||
| MYO1F | myosin IF | 0.011 | ||
| IL12RB2 | interleukin 12 receptor, beta 2 | 0.011 | Human | |
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.011 | ||
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.011 | ||
| LAIR2 | leukocyte-associated immunoglobulin-like receptor 2 | 0.011 | Human | |
| PTGES | prostaglandin E synthase | 0.011 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.011 | ||
| CD72 | CD72 molecule | 0.011 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.011 | ||
| CPVL | carboxypeptidase, vitellogenic-like | 0.011 | ||
| KIR2DL3 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 | 0.011 | ||
| TGFA | transforming growth factor, alpha | 0.011 | ||
| IL1F9 | interleukin 1 family, member 9 | 0.010 | Human | |
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.010 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.010 | ||
| NRP2 | neuropilin 2 | 0.010 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.010 | ||
| CD96 | CD96 molecule | 0.010 | ||
| FPR2 | formyl peptide receptor 2 | 0.010 | ||
| PXN | paxillin | 0.010 | ||
| ABI1 | abl-interactor 1 | 0.010 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.010 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.010 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.010 | ||
| GPSM3 | G-protein signaling modulator 3 | 0.010 | ||
| RUNX1 | runt-related transcription factor 1 | 0.010 | ||
| IL1F5 | interleukin 1 family, member 5 (delta) | 0.010 | ||
| ZNF259 | zinc finger protein 259 | 0.010 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.010 | ||
| CD53 | CD53 molecule | 0.010 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.010 | ||
| ROBO2 | roundabout, axon guidance receptor, homolog 2 (Drosophila) | 0.010 | ||
| IL3RA | interleukin 3 receptor, alpha (low affinity) | 0.010 | ||
| CP | ceruloplasmin (ferroxidase) | 0.010 | ||
| ANXA1 | annexin A1 | 0.010 | ||
| FBLN1 | fibulin 1 | 0.010 | ||
| PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.010 | ||
| RNF2 | ring finger protein 2 | 0.010 |